Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Statistics

Total Valuation

VRCA has a market cap or net worth of $83.61 million. The enterprise value is $98.25 million.

Market Cap	83.61M
Enterprise Value	98.25M

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

VRCA has 9.49 million shares outstanding. The number of shares has increased by 89.19% in one year.

Current Share Class	9.49M
Shares Outstanding	9.49M
Shares Change (YoY)	+89.19%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	87.98%
Owned by Institutions (%)	9.85%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.52
Forward PS	2.47
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.25

Current Ratio	1.25
Quick Ratio	0.98
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-26.28%
Return on Invested Capital (ROIC)	-61.09%
Return on Capital Employed (ROCE)	-129.46%
Revenue Per Employee	$434,211
Profits Per Employee	-$366,394
Employee Count	71
Asset Turnover	0.84
Inventory Turnover	4.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.97% in the last 52 weeks. The beta is 1.50, so VRCA's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	-25.97%
50-Day Moving Average	4.58
200-Day Moving Average	5.48
Relative Strength Index (RSI)	70.61
Average Volume (20 Days)	378,377

Short Selling Information

The latest short interest is 446,691, so 4.71% of the outstanding shares have been sold short.

Short Interest	446,691
Short Previous Month	419,718
Short % of Shares Out	4.71%
Short % of Float	n/a
Short Ratio (days to cover)	2.04

Income Statement

In the last 12 months, VRCA had revenue of $30.83 million and -$26.01 million in losses. Loss per share was -$2.96.

Revenue	30.83M
Gross Profit	20.66M
Operating Income	-15.52M
Pretax Income	-26.01M
Net Income	-26.01M
EBITDA	-14.96M
EBIT	-15.52M
Loss Per Share	-$2.96

Balance Sheet

The company has $21.10 million in cash and $35.74 million in debt, giving a net cash position of -$14.64 million or -$1.54 per share.

Cash & Cash Equivalents	21.10M
Total Debt	35.74M
Net Cash	-14.64M
Net Cash Per Share	-$1.54
Equity (Book Value)	-17.04M
Book Value Per Share	-1.80
Working Capital	7.37M

Cash Flow

Operating Cash Flow	-29.10M
Capital Expenditures	n/a
Free Cash Flow	-29.10M
FCF Per Share	-$3.07

Margins

Gross margin is 67.02%, with operating and profit margins of -50.34% and -84.38%.

Gross Margin	67.02%
Operating Margin	-50.34%
Pretax Margin	-84.38%
Profit Margin	-84.38%
EBITDA Margin	-48.52%
EBIT Margin	-50.34%
FCF Margin	n/a

Dividends & Yields

VRCA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-89.19%
Shareholder Yield	-89.19%
Earnings Yield	-31.11%
FCF Yield	-34.81%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	77.18%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 25, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

VRCA has an Altman Z-Score of -10.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.53
Piotroski F-Score	3